To examine the importance of YAP/TAZ activation under EGFR in HNSCC and lung adenocarcinoma cells, we genome edited the LATS1 and LATS2 genes to activate YAP/TAZ in both cells harboring EGFR alterations. The gene discussed is LATS2; the disease is lung adenocarcinoma.